Loading…

Frequency and Practice-Level Variation in Inappropriate and Nonrecommended Prasugrel Prescribing

The current American College of Cardiology Foundation/American Heart Association guidelines for patients with ST-segment elevation myocardial infarction and unstable angina/non-ST-segment elevation myocardial infarction (3,4) assign a Class I recommendation for prasugrel use at the time of percutane...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2014-07, Vol.63 (25), p.2876-2877
Main Authors: Hira, Ravi S., MD, Kennedy, Kevin, MS, Jneid, Hani, MD, Alam, Mahboob, MD, Basra, Sukhdeep S., MD, MPH, Petersen, Laura A., MD, MPH, Ballantyne, Christie M., MD, Nambi, Vijay, MD, PhD, Chan, Paul S., MD, MSc, Virani, Salim S., MD, PhD
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c2191-1f04a62c597e89d9c1ada234e3515d7186986a47f37078e85eaaa85982fbc1343
cites cdi_FETCH-LOGICAL-c2191-1f04a62c597e89d9c1ada234e3515d7186986a47f37078e85eaaa85982fbc1343
container_end_page 2877
container_issue 25
container_start_page 2876
container_title Journal of the American College of Cardiology
container_volume 63
creator Hira, Ravi S., MD
Kennedy, Kevin, MS
Jneid, Hani, MD
Alam, Mahboob, MD
Basra, Sukhdeep S., MD, MPH
Petersen, Laura A., MD, MPH
Ballantyne, Christie M., MD
Nambi, Vijay, MD, PhD
Chan, Paul S., MD, MSc
Virani, Salim S., MD, PhD
description The current American College of Cardiology Foundation/American Heart Association guidelines for patients with ST-segment elevation myocardial infarction and unstable angina/non-ST-segment elevation myocardial infarction (3,4) assign a Class I recommendation for prasugrel use at the time of percutaneous coronary intervention (PCI) and a Class III (harm) recommendation for its use in patients with history of TIA or stroke. Patients in the appropriate indication group had higher rates of private insurance and treatment by a physician provider; patients in the inappropriate indication group had a higher prevalence of comorbidities such as diabetes, hypertension, dyslipidemia, atrial fibrillation, heart failure, peripheral artery disease, and coronary arterial bypass graft surgery.
doi_str_mv 10.1016/j.jacc.2014.04.011
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1547338985</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0735109714021421</els_id><sourcerecordid>3380225751</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2191-1f04a62c597e89d9c1ada234e3515d7186986a47f37078e85eaaa85982fbc1343</originalsourceid><addsrcrecordid>eNpFkFtLAzEQhYMoWKt_wKcFn7dmks1u8iJI8VIoWvDyGtPsbMnaZmvSFvrvzbaCMDAwnDNz5iPkGugIKJS37ag11o4YhWJEUwGckAEIIXMuVHVKBrTiIgeqqnNyEWNLKS0lqAH5egz4s0Vv95nxdTYLxm6cxXyKO1xmnyY4s3Gdz5zPJt6s16Fb9yM8qF86H9B2qxX6Gg_muF2E5JsFjDa4ufOLS3LWmGXEq78-JB-PD-_j53z6-jQZ309zy0BBDg0tTMlsSotS1cqCqQ3jBXIBoq5AlkqWpqgaXtFKohRojJFCSdbMLfCCD8nNcW-KmB6KG9122-DTSQ2iqDiXSoqkYkeVDV2MARud3lmZsNdAdU9St7onqXuSmqYCSKa7owlT_p3DoO3SeWfN8hv3GP_v6Mg01W896x41FJRBwYD_Am4GfOY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1547338985</pqid></control><display><type>article</type><title>Frequency and Practice-Level Variation in Inappropriate and Nonrecommended Prasugrel Prescribing</title><source>BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS</source><creator>Hira, Ravi S., MD ; Kennedy, Kevin, MS ; Jneid, Hani, MD ; Alam, Mahboob, MD ; Basra, Sukhdeep S., MD, MPH ; Petersen, Laura A., MD, MPH ; Ballantyne, Christie M., MD ; Nambi, Vijay, MD, PhD ; Chan, Paul S., MD, MSc ; Virani, Salim S., MD, PhD</creator><creatorcontrib>Hira, Ravi S., MD ; Kennedy, Kevin, MS ; Jneid, Hani, MD ; Alam, Mahboob, MD ; Basra, Sukhdeep S., MD, MPH ; Petersen, Laura A., MD, MPH ; Ballantyne, Christie M., MD ; Nambi, Vijay, MD, PhD ; Chan, Paul S., MD, MSc ; Virani, Salim S., MD, PhD</creatorcontrib><description>The current American College of Cardiology Foundation/American Heart Association guidelines for patients with ST-segment elevation myocardial infarction and unstable angina/non-ST-segment elevation myocardial infarction (3,4) assign a Class I recommendation for prasugrel use at the time of percutaneous coronary intervention (PCI) and a Class III (harm) recommendation for its use in patients with history of TIA or stroke. Patients in the appropriate indication group had higher rates of private insurance and treatment by a physician provider; patients in the inappropriate indication group had a higher prevalence of comorbidities such as diabetes, hypertension, dyslipidemia, atrial fibrillation, heart failure, peripheral artery disease, and coronary arterial bypass graft surgery.</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/j.jacc.2014.04.011</identifier><language>eng</language><publisher>New York: Elsevier Limited</publisher><subject>Acute coronary syndromes ; Age ; Cardiology ; Cardiovascular ; Cardiovascular disease ; Confidence intervals ; Diabetes ; Heart attacks ; Heart failure ; Hypertension ; Internal Medicine ; Stroke</subject><ispartof>Journal of the American College of Cardiology, 2014-07, Vol.63 (25), p.2876-2877</ispartof><rights>American College of Cardiology Foundation</rights><rights>Copyright Elsevier Limited Jul 1, 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2191-1f04a62c597e89d9c1ada234e3515d7186986a47f37078e85eaaa85982fbc1343</citedby><cites>FETCH-LOGICAL-c2191-1f04a62c597e89d9c1ada234e3515d7186986a47f37078e85eaaa85982fbc1343</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Hira, Ravi S., MD</creatorcontrib><creatorcontrib>Kennedy, Kevin, MS</creatorcontrib><creatorcontrib>Jneid, Hani, MD</creatorcontrib><creatorcontrib>Alam, Mahboob, MD</creatorcontrib><creatorcontrib>Basra, Sukhdeep S., MD, MPH</creatorcontrib><creatorcontrib>Petersen, Laura A., MD, MPH</creatorcontrib><creatorcontrib>Ballantyne, Christie M., MD</creatorcontrib><creatorcontrib>Nambi, Vijay, MD, PhD</creatorcontrib><creatorcontrib>Chan, Paul S., MD, MSc</creatorcontrib><creatorcontrib>Virani, Salim S., MD, PhD</creatorcontrib><title>Frequency and Practice-Level Variation in Inappropriate and Nonrecommended Prasugrel Prescribing</title><title>Journal of the American College of Cardiology</title><description>The current American College of Cardiology Foundation/American Heart Association guidelines for patients with ST-segment elevation myocardial infarction and unstable angina/non-ST-segment elevation myocardial infarction (3,4) assign a Class I recommendation for prasugrel use at the time of percutaneous coronary intervention (PCI) and a Class III (harm) recommendation for its use in patients with history of TIA or stroke. Patients in the appropriate indication group had higher rates of private insurance and treatment by a physician provider; patients in the inappropriate indication group had a higher prevalence of comorbidities such as diabetes, hypertension, dyslipidemia, atrial fibrillation, heart failure, peripheral artery disease, and coronary arterial bypass graft surgery.</description><subject>Acute coronary syndromes</subject><subject>Age</subject><subject>Cardiology</subject><subject>Cardiovascular</subject><subject>Cardiovascular disease</subject><subject>Confidence intervals</subject><subject>Diabetes</subject><subject>Heart attacks</subject><subject>Heart failure</subject><subject>Hypertension</subject><subject>Internal Medicine</subject><subject>Stroke</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNpFkFtLAzEQhYMoWKt_wKcFn7dmks1u8iJI8VIoWvDyGtPsbMnaZmvSFvrvzbaCMDAwnDNz5iPkGugIKJS37ag11o4YhWJEUwGckAEIIXMuVHVKBrTiIgeqqnNyEWNLKS0lqAH5egz4s0Vv95nxdTYLxm6cxXyKO1xmnyY4s3Gdz5zPJt6s16Fb9yM8qF86H9B2qxX6Gg_muF2E5JsFjDa4ufOLS3LWmGXEq78-JB-PD-_j53z6-jQZ309zy0BBDg0tTMlsSotS1cqCqQ3jBXIBoq5AlkqWpqgaXtFKohRojJFCSdbMLfCCD8nNcW-KmB6KG9122-DTSQ2iqDiXSoqkYkeVDV2MARud3lmZsNdAdU9St7onqXuSmqYCSKa7owlT_p3DoO3SeWfN8hv3GP_v6Mg01W896x41FJRBwYD_Am4GfOY</recordid><startdate>20140701</startdate><enddate>20140701</enddate><creator>Hira, Ravi S., MD</creator><creator>Kennedy, Kevin, MS</creator><creator>Jneid, Hani, MD</creator><creator>Alam, Mahboob, MD</creator><creator>Basra, Sukhdeep S., MD, MPH</creator><creator>Petersen, Laura A., MD, MPH</creator><creator>Ballantyne, Christie M., MD</creator><creator>Nambi, Vijay, MD, PhD</creator><creator>Chan, Paul S., MD, MSc</creator><creator>Virani, Salim S., MD, PhD</creator><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20140701</creationdate><title>Frequency and Practice-Level Variation in Inappropriate and Nonrecommended Prasugrel Prescribing</title><author>Hira, Ravi S., MD ; Kennedy, Kevin, MS ; Jneid, Hani, MD ; Alam, Mahboob, MD ; Basra, Sukhdeep S., MD, MPH ; Petersen, Laura A., MD, MPH ; Ballantyne, Christie M., MD ; Nambi, Vijay, MD, PhD ; Chan, Paul S., MD, MSc ; Virani, Salim S., MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2191-1f04a62c597e89d9c1ada234e3515d7186986a47f37078e85eaaa85982fbc1343</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Acute coronary syndromes</topic><topic>Age</topic><topic>Cardiology</topic><topic>Cardiovascular</topic><topic>Cardiovascular disease</topic><topic>Confidence intervals</topic><topic>Diabetes</topic><topic>Heart attacks</topic><topic>Heart failure</topic><topic>Hypertension</topic><topic>Internal Medicine</topic><topic>Stroke</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hira, Ravi S., MD</creatorcontrib><creatorcontrib>Kennedy, Kevin, MS</creatorcontrib><creatorcontrib>Jneid, Hani, MD</creatorcontrib><creatorcontrib>Alam, Mahboob, MD</creatorcontrib><creatorcontrib>Basra, Sukhdeep S., MD, MPH</creatorcontrib><creatorcontrib>Petersen, Laura A., MD, MPH</creatorcontrib><creatorcontrib>Ballantyne, Christie M., MD</creatorcontrib><creatorcontrib>Nambi, Vijay, MD, PhD</creatorcontrib><creatorcontrib>Chan, Paul S., MD, MSc</creatorcontrib><creatorcontrib>Virani, Salim S., MD, PhD</creatorcontrib><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hira, Ravi S., MD</au><au>Kennedy, Kevin, MS</au><au>Jneid, Hani, MD</au><au>Alam, Mahboob, MD</au><au>Basra, Sukhdeep S., MD, MPH</au><au>Petersen, Laura A., MD, MPH</au><au>Ballantyne, Christie M., MD</au><au>Nambi, Vijay, MD, PhD</au><au>Chan, Paul S., MD, MSc</au><au>Virani, Salim S., MD, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Frequency and Practice-Level Variation in Inappropriate and Nonrecommended Prasugrel Prescribing</atitle><jtitle>Journal of the American College of Cardiology</jtitle><date>2014-07-01</date><risdate>2014</risdate><volume>63</volume><issue>25</issue><spage>2876</spage><epage>2877</epage><pages>2876-2877</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><abstract>The current American College of Cardiology Foundation/American Heart Association guidelines for patients with ST-segment elevation myocardial infarction and unstable angina/non-ST-segment elevation myocardial infarction (3,4) assign a Class I recommendation for prasugrel use at the time of percutaneous coronary intervention (PCI) and a Class III (harm) recommendation for its use in patients with history of TIA or stroke. Patients in the appropriate indication group had higher rates of private insurance and treatment by a physician provider; patients in the inappropriate indication group had a higher prevalence of comorbidities such as diabetes, hypertension, dyslipidemia, atrial fibrillation, heart failure, peripheral artery disease, and coronary arterial bypass graft surgery.</abstract><cop>New York</cop><pub>Elsevier Limited</pub><doi>10.1016/j.jacc.2014.04.011</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0735-1097
ispartof Journal of the American College of Cardiology, 2014-07, Vol.63 (25), p.2876-2877
issn 0735-1097
1558-3597
language eng
recordid cdi_proquest_journals_1547338985
source BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS
subjects Acute coronary syndromes
Age
Cardiology
Cardiovascular
Cardiovascular disease
Confidence intervals
Diabetes
Heart attacks
Heart failure
Hypertension
Internal Medicine
Stroke
title Frequency and Practice-Level Variation in Inappropriate and Nonrecommended Prasugrel Prescribing
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T07%3A42%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Frequency%20and%20Practice-Level%20Variation%20in%20Inappropriate%20and%20Nonrecommended%20Prasugrel%20Prescribing&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Hira,%20Ravi%20S.,%20MD&rft.date=2014-07-01&rft.volume=63&rft.issue=25&rft.spage=2876&rft.epage=2877&rft.pages=2876-2877&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/j.jacc.2014.04.011&rft_dat=%3Cproquest_cross%3E3380225751%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2191-1f04a62c597e89d9c1ada234e3515d7186986a47f37078e85eaaa85982fbc1343%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1547338985&rft_id=info:pmid/&rfr_iscdi=true